54 related articles for article (PubMed ID: 26479501)
1. Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirus.
Yano S; Miwa S; Kishimoto H; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
J Orthop Res; 2016 May; 34(5):836-44. PubMed ID: 26479501
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
[TBL] [Abstract][Full Text] [Related]
3. Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery.
Yano S; Hiroshima Y; Maawy A; Kishimoto H; Suetsugu A; Miwa S; Toneri M; Yamamoto M; Katz MH; Fleming JB; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Cancer Gene Ther; 2015 Jul; 22(7):344-50. PubMed ID: 26088297
[TBL] [Abstract][Full Text] [Related]
4. A Novel Orthotopic Mouse Model of Lung Metastasis Using Fluorescent Patient-derived Osteosarcoma Cells.
Oshiro H; Tome Y; Miyake K; Higuchi T; Sugisawa N; Park JH; Zhang Z; Razmjooei S; Kanaya F; Nishida K; Hoffman RM
Anticancer Res; 2021 Feb; 41(2):635-640. PubMed ID: 33517267
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive Fluorescence Imaging of Breast Cancer Metastasis to the Brain in an Orthotopic Nude-mouse Model With Very-narrow-band-width Laser Excitation of Red Fluorescent Protein Resulting in an Ultra-bright Signal Without Skin Autofluorescence.
Kubota Y; Aoki Y; Wang A; Chang N; Tarantino S; Gallagher S; Tsunoda T; Hoffman RM
In Vivo; 2024; 38(1):69-72. PubMed ID: 38148053
[TBL] [Abstract][Full Text] [Related]
6. Development of a drug-device combination for fluorescence-guided surgery in neuroendocrine tumors.
Hernandez Vargas S; Lin C; Voss J; Ghosh SC; Halperin DM; AghaAmiri S; Cao HST; Ikoma N; Uselmann AJ; Azhdarinia A
J Biomed Opt; 2020 Dec; 25(12):. PubMed ID: 33300316
[TBL] [Abstract][Full Text] [Related]
7. Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777.
Thanindratarn P; Li X; Dean DC; Nelson SD; Hornicek FJ; Duan Z
J Orthop Res; 2020 Apr; 38(4):902-910. PubMed ID: 31736134
[TBL] [Abstract][Full Text] [Related]
8. Highly metastatic K7M2 cell line: A novel murine model capable of in vivo imaging via luciferase vector transfection.
Grisez BT; Ray JJ; Bostian PA; Markel JE; Lindsey BA
J Orthop Res; 2018 Feb; ():. PubMed ID: 29427436
[TBL] [Abstract][Full Text] [Related]
9. Efficient and Consistent Orthotopic Osteosarcoma Model by Cell Sheet Transplantation in the Nude Mice for Drug Testing.
Wu H; He Z; Li X; Xu X; Zhong W; Bu J; Huang G
Front Bioeng Biotechnol; 2021; 9():690409. PubMed ID: 34631675
[TBL] [Abstract][Full Text] [Related]
10. Assessment of open-field fluorescence guided surgery systems: implementing a standardized method for characterization and comparison.
Ochoa MI; Ruiz A; LaRochelle E; Reed M; Berber E; Poultsides G; Pogue BW
J Biomed Opt; 2023 Sep; 28(9):096007. PubMed ID: 37745774
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence Image-Guided Surgery - a Perspective on Contrast Agent Development.
Barth CW; Gibbs SL
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 32255887
[TBL] [Abstract][Full Text] [Related]
12. Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.
Yano S; Tazawa H; Kishimoto H; Kagawa S; Fujiwara T; Hoffman RM
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477279
[TBL] [Abstract][Full Text] [Related]
13. Bone and Soft-Tissue Sarcoma: A New Target for Telomerase-Specific Oncolytic Virotherapy.
Tazawa H; Hasei J; Yano S; Kagawa S; Ozaki T; Fujiwara T
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32085583
[TBL] [Abstract][Full Text] [Related]
14. Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
Samkoe KS; Sardar HS; Gunn J; Feldwisch J; Linos K; Henderson E; Pogue B; Paulsen K
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10862():. PubMed ID: 31595101
[TBL] [Abstract][Full Text] [Related]
15. Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.
Lwin TM; Hoffman RM; Bouvet M
J Surg Oncol; 2018 Aug; 118(2):253-264. PubMed ID: 30080930
[TBL] [Abstract][Full Text] [Related]
16. Application of Fluorescence-Guided Surgery to Subsurface Cancers Requiring Wide Local Excision: Literature Review and Novel Developments Toward Indirect Visualization.
Samkoe KS; Bates BD; Elliott JT; LaRochelle E; Gunn JR; Marra K; Feldwisch J; Ramkumar DB; Bauer DF; Paulsen KD; Pogue BW; Henderson ER
Cancer Control; 2018; 25(1):1073274817752332. PubMed ID: 29334791
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a connective tissue phantom model for subsurface visualization of cancers requiring wide local excision.
Samkoe KS; Bates BD; Tselepidakis NN; DSouza AV; Gunn JR; Ramkumar DB; Paulsen KD; Pogue BW; Henderson ER
J Biomed Opt; 2017 Dec; 22(12):1-12. PubMed ID: 29274143
[TBL] [Abstract][Full Text] [Related]
18. Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).
Cai Z; Lv H; Cao W; Zhou C; Liu Q; Li H; Zhou F
Mol Med Rep; 2017 Nov; 16(5):6443-6458. PubMed ID: 28901490
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
